Respiratory syncytial virus infection in immunocompromised patients revisited

Clinical Infectious Diseases

Volumn 46, Issue 12, 2008, Pages 1934-1935

  Khanna, Nina ^b   Hirsch, Hans H ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

MOTAVIZUMAB; PALIVIZUMAB; RIBAVIRIN;

ACUTE GRANULOCYTIC LEUKEMIA; AEROSOL; ARTIFICIAL VENTILATION; DISEASE COURSE; DRUG TOLERABILITY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNE DEFICIENCY; IMMUNOCOMPROMISED PATIENT; IMMUNOGLOBULIN DEFICIENCY; INTENSIVE CARE UNIT; LETTER; LEUKOPENIA; LOWER RESPIRATORY TRACT INFECTION; LYMPHOCYTOPENIA; MORTALITY; PEDIATRICS; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; THERAPY DELAY; UPPER RESPIRATORY TRACT INFECTION; VIRUS INFECTION;

EID: 53349174247     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/588560     Document Type: Letter

References (4)

1. Simon A, Schildgen O, Panning M, Bode U, Eis-Huebinger AM. Respiratory syncytial virus infection in patients with cancer: still more questions than answers. Clin Infect Dis 2008; 46:1933-4 (in this issue).
2. Khanna N, Widmer AF, Decker M, et al. Respiratory syncytial virus infection in patients with hematological diseases: single-center study and review of the literature. Clin Infect Dis 2008; 46:402-12.
3. Chavez-Bueno S, Mejias A, Merryman RA, Ahmad N, Jafri HS, Ramilo O. Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients. Pediatr Infect Dis J 2007; 26:1089-93.
4. de Fontbrune FS, Robin M, Porcher R, et al. Palivizumab treatment of respiratory syncytial virus infection after allogeneic hematopoietic stem cell transplantation. Clin Infect Dis 2007; 45:1019-24.